Encompass Health Corporation announced its upcoming investor meetings on June 4 and June 18, 2025, while reiterating its 2025 financial guidance, projecting net revenue of $5.85 billion to $5.93 billion, adjusted EBITDA of $1.185 billion to $1.22 billion, and adjusted earnings per share of $4.85 to $5.10.